Literature DB >> 26682784

DPP-4 inhibition and blood pressure lowering in perspective.

Peter M Nilsson1, Javier Diez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26682784     DOI： 10.1097/HJH.0000000000000814

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  2 in total

1.  Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients.

Authors:  Raffaella Dell'Oro; Alessandro Maloberti; Francesco Nicoli; Paolo Villa; Pierluigi Gamba; Michele Bombelli; Giuseppe Mancia; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-06-12

2.  DPP4 inhibition mitigates ANG II-mediated kidney immune activation and injury in male mice.

Authors:  Ravi Nistala; Alex I Meuth; Cassandra Smith; Jianzhong An; Javad Habibi; M R Hayden; Megan Johnson; Annayya Aroor; Adam Whaley-Connell; James R Sowers; Susan C McKarns; Shawn B Bender
Journal:  Am J Physiol Renal Physiol       Date:  2021-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.